[Genetics of blood coagulation in young stroke patients]
- PMID: 12122980
[Genetics of blood coagulation in young stroke patients]
Abstract
Background and purpose: The classical risk factors did not explain all the possible etiology of cerebral stroke. Genetic polymorphisms responsible for thrombophilia were implicated recently as risk factors of stroke. In this genetico-epidemiological study the author's aim was to analyse the tendency of genetic polymorphisms to cluster in a cohort of young and elderly stroke patients and in healthy subjects in Hungary.
Methods: 253 patients with stroke were compared with 173 healthy blood donors on the basis of genetic polymorphisms of platelet GP IIb/IIIa receptor (33 LeuPro), prothrombin gene G20210A, Factor V Leiden mutation, ACE I/D, methylenetetrahydrofolate reductase (MTHFR) and beta fibrinogen gene G455A. These data were acquired using PCR. Questionnaires were used to investigate the family history and to determine the risk factor profile. The subtypes of stroke were analysed in a stroke cohort grouped according to different polymorphisms.
Results: An increased frequency of GP IIIa heterozygosity was found as compared to a West-European stroke cohort (31% versus 19%). The prothrombin gene variant (2.9% European and 4.8% in Hungary) was also found to increase in frequency. In young stroke patients (age < 50) compared with control subjects the odds ratios were higher: in prothrombin gene (OR: 4.9), in Leiden mutation (OR: 1.67), in fibrinogen gene (OR: 1.64) and in MTHFR(+/+) (OR: 1.58). Clustering of two polymorphisms could only be detected in young patients. These clustering polymorphisms were GP IIb/IIIa with prothrombin G20210A variant (OR: 6.74, 95% CI 1.1-18.2) and prothrombin gene variant with MTHFR (OR: 5.3, CI95 1.2-8.3).
Conclusion: Selected and clustered genetic polymorphisms of haemostatic factors could be responsible for the high stroke morbidity in Central Europe. The presence and clustering tendency of these factors have been described in young stroke victims.
Similar articles
-
Evaluation of the interactions of common genetic mutations in stroke subtypes.J Neurol. 2002 Oct;249(10):1391-7. doi: 10.1007/s00415-002-0848-4. J Neurol. 2002. PMID: 12382154
-
[Risk of thrombophilia in carriers of thrombophilic genetic factors in unsuccessful assisted reproduction].Akush Ginekol (Sofiia). 2007;46(6):3-8. Akush Ginekol (Sofiia). 2007. PMID: 17974163 Bulgarian.
-
Connection between genetically determined blood coagulation factors and haemorheology.Clin Hemorheol Microcirc. 2008;39(1-4):333-41. Clin Hemorheol Microcirc. 2008. PMID: 18503143
-
Genetic risk factors in myocardial infarction at young age.Minerva Cardioangiol. 2004 Aug;52(4):287-312. Minerva Cardioangiol. 2004. PMID: 15284679 Review.
-
Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.Am Heart J. 2003 Dec;146(6):948-57. doi: 10.1016/S0002-8703(03)00519-2. Am Heart J. 2003. PMID: 14660985 Review.
Cited by
-
Association of G20210A Prothrombin Gene Mutation and Cerebral Ischemic Stroke in Young Patients.Cureus. 2020 Dec 8;12(12):e11984. doi: 10.7759/cureus.11984. Cureus. 2020. PMID: 33437541 Free PMC article. Review.
-
Impact of Early Intravenous Haemostatic Drugs on Brain Haemorrhage Patients and Their Image Segmentation Based on RGB-D Images.J Healthc Eng. 2022 Jan 7;2022:4608648. doi: 10.1155/2022/4608648. eCollection 2022. J Healthc Eng. 2022. Retraction in: J Healthc Eng. 2023 Aug 2;2023:9862989. doi: 10.1155/2023/9862989. PMID: 35035838 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous